IDEXX Laboratories Inc (IDXX)
489.24
-5.02
(-1.02%)
USD |
NASDAQ |
Apr 25, 16:00
495.81
+6.57
(+1.34%)
After-Hours: 06:33
IDEXX Laboratories Enterprise Value: 41.14B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 41.14B |
| April 24, 2024 | 41.56B |
| April 23, 2024 | 41.52B |
| April 22, 2024 | 40.34B |
| April 19, 2024 | 40.07B |
| April 18, 2024 | 40.19B |
| April 17, 2024 | 40.23B |
| April 16, 2024 | 41.17B |
| April 15, 2024 | 41.31B |
| April 12, 2024 | 41.86B |
| April 11, 2024 | 42.30B |
| April 10, 2024 | 42.38B |
| April 09, 2024 | 43.68B |
| April 08, 2024 | 43.26B |
| April 05, 2024 | 43.66B |
| April 04, 2024 | 43.54B |
| April 03, 2024 | 44.04B |
| April 02, 2024 | 43.84B |
| April 01, 2024 | 44.73B |
| March 28, 2024 | 45.36B |
| March 27, 2024 | 45.33B |
| March 26, 2024 | 44.58B |
| March 25, 2024 | 44.51B |
| March 22, 2024 | 44.59B |
| March 21, 2024 | 44.70B |
| Date | Value |
|---|---|
| March 20, 2024 | 44.49B |
| March 19, 2024 | 44.90B |
| March 18, 2024 | 44.52B |
| March 15, 2024 | 44.51B |
| March 14, 2024 | 44.99B |
| March 13, 2024 | 45.38B |
| March 12, 2024 | 45.93B |
| March 11, 2024 | 46.05B |
| March 08, 2024 | 47.14B |
| March 07, 2024 | 47.29B |
| March 06, 2024 | 46.81B |
| March 05, 2024 | 46.88B |
| March 04, 2024 | 47.96B |
| March 01, 2024 | 48.43B |
| February 29, 2024 | 48.29B |
| February 28, 2024 | 47.99B |
| February 27, 2024 | 48.28B |
| February 26, 2024 | 47.84B |
| February 23, 2024 | 48.38B |
| February 22, 2024 | 47.96B |
| February 21, 2024 | 46.59B |
| February 20, 2024 | 46.29B |
| February 16, 2024 | 46.65B |
| February 15, 2024 | 47.76B |
| February 14, 2024 | 47.07B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.49B
Minimum
Mar 23 2020
60.72B
Maximum
Aug 05 2021
37.72B
Average
39.44B
Median
Nov 16 2023
Enterprise Value Benchmarks
| Stryker Corp | 138.15B |
| Haemonetics Corp | 5.129B |
| Align Technology Inc | 22.35B |
| Edwards Lifesciences Corp | 51.94B |
| ACADIA Pharmaceuticals Inc | 2.249B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 194.52M |
| Revenue (Quarterly) | 901.60M |
| Total Expenses (Quarterly) | 656.30M |
| EPS Diluted (Quarterly) | 2.32 |
| Gross Profit Margin (Quarterly) | 58.36% |
| Profit Margin (Quarterly) | 21.58% |
| Earnings Yield | 2.06% |
| Operating Earnings Yield | 2.67% |
| Normalized Earnings Yield | 2.058 |